Outbreak of Carbapenem-Resistant Pseudomonas aeruginosa Producing VIM-8, a Novel Metallo-β-Lactamase, in a Tertiary Care Center in Cali, Colombia
- 1 November 2004
- journal article
- Published by American Society for Microbiology in Journal of Clinical Microbiology
- Vol. 42 (11), 5094-101
- https://doi.org/10.1128/jcm.42.11.5094-5101.2004
Abstract
The prevalence of imipenem resistance among Pseudomonas aeruginosa isolates at a 195-bed tertiary care medical center in Cali, Colombia, rose from 2% in 1996 to 28% in 1997 and to over 40% in 2003. Many isolates showed high-level multiresistance, and phenotypic characterization suggested the spread of a predominant strain with minor variants. Sixty-six resistant isolates collected between February 1999 and July 2003 from hospitalized patients (n = 54) and environmental samples (n = 12) were subjected to a fuller analysis. Genetic fingerprints were compared by pulsed-field gel electrophoresis (PFGE) of SpeI-digested genomic DNA, and bla(IMP) and bla(VIM) genes were sought by PCR. PFGE and serotyping indicated that 52 of the 66 isolates belonged to a single strain, with 82% similarity; the PFGE pattern for this organism was designated pattern A. Two further pairs of isolates represented single strains; the remaining nine isolates were unique, and in the case of one isolate, no satisfactory PFGE profile could be obtained. The pattern A isolates were mostly of serotype O12 and were highly resistant to imipenem (MICs, 32 to >256 microg/ml), with this resistance decreased eightfold or more in the presence of EDTA. They yielded amplicons with bla(VIM)-specific primers, and sequencing of DNA from a representative isolate revealed bla(VIM-8), a novel allele with three polymorphisms compared with the sequence of bla(VIM-2). Two of these nucleotide changes were silent, but the third determined a Thr139Ala substitution. Only 4 of 13 resistant isolates (2 clinical isolates and 2 environmental isolates) assigned to other PFGE types carried bla(VIM) alleles, whereas the others were less multiresistant and mostly had lower levels of imipenem resistance (MICs, < or =32 microg/ml) which was not significantly reduced by EDTA. No bla(IMP) alleles were detected. During 2003, when the environmental study was undertaken, serotype O12 isolates with bla(VIM) were recovered from sinks and stethoscopes in the most-affected units, although not from the hands of staff; the problem declined once these reservoirs were disinfected and hygienic precautions were reinforced.Keywords
This publication has 39 references indexed in Scilit:
- BSAC standardized disc susceptibility testing method (version 3)Journal of Antimicrobial Chemotherapy, 2004
- Hospital outbreak of multiple clones of Pseudomonas aeruginosa carrying the unrelated metallo-beta-lactamase gene variants blaVIM-2 and blaVIM-4Journal of Antimicrobial Chemotherapy, 2003
- Emergence of an IMP-like metallo-enzyme in an Acinetobacter baumannii clinical strain from a Brazilian teaching hospitalDiagnostic Microbiology and Infectious Disease, 2003
- Nosocomial Outbreak of Carbapenem-Resistant Pseudomonas aeruginosa with a New bla IMP Allele, bla IMP-7Antimicrobial Agents and Chemotherapy, 2002
- Metallo-β-Lactamases in Clinical Pseudomonas Isolates in Taiwan and Identification of VIM-3, a Novel Variant of the VIM-2 EnzymeAntimicrobial Agents and Chemotherapy, 2001
- Hospital Outbreak of Carbapenem-Resistant Pseudomonas aeruginosa Producing VIM-1, a Novel Transferable Metallo- -LactamaseClinical Infectious Diseases, 2000
- Carbapenemases: a problem in waiting?Current Opinion in Microbiology, 2000
- Evaluation of Outcome for Intubated Patients with Pneumonia Due to Pseudomonas aeruginosaClinical Infectious Diseases, 1996
- Resistance mechanisms of multiresistant serotype 012 Pseudomonas aeruginosa isolated in EuropeJournal of Antimicrobial Chemotherapy, 1990
- Epidemiological typing ofPseudomonas aeruginosaEuropean Journal of Clinical Microbiology & Infectious Diseases, 1988